クオンタム・サイバーNV
Mainz Biomed N.V.
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.43 | $0 | -$3M |
| 2025 Q2 | 0.00 | $286,717 | -$3M |